SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brera Holdings Plc engages in the business of football division progression, global football player transfer service, sponsorship services, football school services, and consulting services on football projects. The company was founded on June 30, 2022 and is headquartered in Dublin, Ireland.

Brera Holdings PLC - Ordinary Shares - Class B

Brera Holdings PLC

BREA is trending due to its rebranding as Solmate and a $300M investment for a Solana-based digital asset treasury, with ARK Invest's involvement further fueling interest. The community is discussing the potential for significant growth, drawing comparisons to other crypto treasury stocks, while also weighing the risks of dilution.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc is trending as chatter around AI AR smartglasses, potential buyouts, and increased user engagement drive interest. The community is buzzing about the company's potential to compete with tech giants in the AR space, along with speculation on how it might benefit from regulatory changes impacting competitors like TikTok. High options volume and bullish sentiment suggest strong conviction in the stock's near-term prospects.

FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Freight, Corporate, Other, and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN.

Fedex Corp

After initially rising on better-than-expected earnings, $FDX is now trending lower as investors react to cautious commentary and a weaker outlook due to global trade uncertainty. The community is actively debating the impact of tariffs and potential downgrades, with some anticipating a continued decline. Despite solid Q4 results, the lack of full-year guidance is fueling concerns about future performance, sparking discussions around potential buying opportunities or further downside risk.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending as analysts raise price targets ahead of earnings, citing strong AI-driven demand and tight memory supply. Community members are actively discussing whether to take profits or hold through earnings, with some pointing to the stock's overbought conditions and potential for a pullback. The stock's strong performance is also drawing comparisons to past market trends and other high-growth tech companies.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co.

Recent conversations around Disney ($DIS) are centered on the suspension of Jimmy Kimmel's show and potential boycotts, sparking debates about free speech and political polarization. Community viewpoints are divided, with some celebrating the decision and others criticizing it as a concession to political pressure. The broader context involves Disney navigating streaming profitability, balancing content strategy with political sensitivities, and facing challenges in linear TV.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Recent discussions around $DJT are centered on potential First Amendment issues, particularly regarding media criticism and censorship. The community is debating the implications of actions taken against media figures and networks, with some viewing them as attacks on free speech. The stock is also caught in broader political debates, influencing its volatile nature.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as investors digest news and commentary from recent conferences, with community chatter focusing on production timelines for the R2, potential partnerships, and the company's overall financial health. Discussions also revolve around Rivian's long-term viability in a competitive EV market and the impact of potential government incentives.

FatPipe, Inc. engages in the development of software-defined wide area network (SD-WAN) solutions for organizations, including enterprises, communication service providers, security service providers, government organizations, and other middle-market companies. Its products include WARP, MPVPN, SD-WAN, Fatpipe Orchestrator, Next Gen Firewall, 5G and LTE, FatPipe Total Security 360, SASE, SIEM, EnterpriseView, and Cloud Connect. The company was founded by Ragula Bhaskar and Sanchaita Datta on October 14, 2010 and is headquartered in Salt Lake City, UT.

Fatpipe Inc.

FatPipe, Inc. Common Stock

FATN is trending due to increased attention on its low float and potential for a short squeeze, with community members actively discussing potential breakouts and accumulation patterns. The stock's recent IPO and solid fundamentals are also contributing to the heightened interest, as traders anticipate significant price movement with increased volume or news catalysts. Some investors believe the company could be an acquisition target.

Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Imunon Inc

IMNN is trending due to ongoing discussions about its Phase 3 trial for ovarian cancer treatment, with community members highlighting the potential of the TheraPlas technology. Some investors express optimism, citing successful Phase 2 data and a relatively low market cap, while others worry about potential dilution and the company's history of reverse stock splits. The stock's volatile price action and recent news about Nasdaq compliance are also fueling the conversation.

AlphaVest Acquisition Corp. is a blank check company, which engages in effecting a merger, stock exchange, asset acquisition, stock purchase, and reorganization or similar business combination. The company was founded on January 14, 2022 and is headquartered in New York, NY.

AlphaVest Acquisition Corp

AlphaVest Acquisition Corp (ATMV) is trending due to significant pre-market and intraday price volatility, triggering multiple trading halts. Community discussions revolve around the stock's momentum, potential for further gains, and the risks associated with its volatile behavior, with some speculating about news pending or a potential merger agreement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why

J&J sees Innovative Medicines growth in 2025, fueled by oncology and immunology drugs, despite steep Stelara sales erosion.

NVO Stock Rises on Upbeat Phase III Data for Cagrilintide in Obesity

Novo Nordisk stock rises as its next-generation subcutaneous obesity treatment candidate, cagrilintide, delivers meaningful weight loss in a phase III obesity study.

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play?

Amgen's MariTide and Viking's VK2735 show promise in obesity, but pipeline strength and performance set the two biotech players apart.

Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now?

Eli Lilly shares move past the 50-day SMA as weight-loss drug data, rising sales and pipeline momentum fuel optimism.

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Where Does VKTX Stock Stand After the Obesity Pill Setback?

Viking Therapeutics faces pressure after mixed oral obesity pill trial results, raising safety concerns but still meeting key study goals.

Is NVO's Major Restructuring Plan an Indication to Sell the Stock?

Novo Nordisk's sweeping restructuring plan cuts 9,000 jobs, targets DKK 8 billion in savings, and shifts focus to obesity and diabetes R&D.

Zai Lab (ZLAB) announced on Wednesday that it plans to await the results of a trial evaluating Bemarituzumab in combination with Nivolumab and chemotherapy before filing for regulatory approval for the experimental cancer drug.The data from the trial is expected by the end of 2025 or the first half of 2026, the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0903/2025090302254.pdf">said</a> in a filing with the Hong Kong stock exchange. Nasdaq-listed <a href="https://stocktwits.com/symbol/ZLAB">shares of Zai Lab</a> were down 4% at the time of writing.On Stocktwits, retail sentiment around ZLAB stayed within ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘normal’ levels.The announcement from the company follows its partner Amgen's (AMGN) completion of the final analysis of the late-stage trial evaluating Bemarituzumab in combination with Chemotherapy in first-line gastric cancer.Amgen <a href="https://stocktwits.com/news-articles/markets/equity/amgen-cancer-drug-improves-survival-in-late-stage-trial/chmZZAcRR79">said</a> in late June that Bemarituzumab plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement in overall survival as compared to placebo plus chemotherapy in people living with certain types of unresectable locally advanced or metastatic gastric or gastroesophageal junction cancer. Overall survival refers to the total length of time a patient with cancer remains alive after diagnosis or the initiation of treatment.However, Zai Lab said on Wednesday that, upon final analysis of the trial, the magnitude of the previously observed survival benefit was reduced, leading the company to await the results of another trial.Zai Lab holds co-development and commercialization rights for Bemarituzumab for mainland China, Hong Kong, Macau, and Taiwan.ZLAB shares are up 22% this year and approximately 66% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/ford-reports-near-four-percent-jump-in-us-vehicle-sales-in-august/chwT6RHRd8r">Ford Reports Near 4% Jump In US Vehicle Sales In August</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Zai Lab company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Zai Lab To Await More Trial Data Before Filing For Regulatory Approval For Experimental Cancer Drug

The company holds co-development and commercialization rights for Bemarituzumab for mainland China, Hong Kong, Macau, and Taiwan.

Equity

The company holds co-development and commercialization rights for Bemarituzumab for mainland China, Hong Kong, Macau, and Taiwan.


Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

AMGN
AMGEN Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AMGN News

AMGN AMGEN Inc.